Ibutilide Pregnancy and Breastfeeding Warnings
Brand names: Corvert
Medically reviewed by Drugs.com. Last updated on Oct 4, 2024.
Ibutilide Pregnancy Warnings
This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus.
US FDA pregnancy category: C
Animal studies have revealed evidence of teratogenicity and embryolethality. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Ibutilide Breastfeeding Warnings
Use should be avoided.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2001) "Product Information. Corvert (ibutilide)." Pharmacia and Upjohn
References for breastfeeding information
- (2001) "Product Information. Corvert (ibutilide)." Pharmacia and Upjohn
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.